HIFU PLANET website receives HonCode certification

HIFU Planet, our website dedicated to patient information on prostate cancer and Ablatherm® HIFU treatment just received HONcode certification.You can visit the websites www.hifu-planet.co.uk and www.hifu-planet.fr . HONcode is the oldest and the most used ethical and trustworthy code for medical and health related information available on Internet. We are proud to bear this internationnally renowned certification and to provide reliable information for patients.

Fist Sonolith® i-sys lithotripter in operation in Japan After receiving approval from Japanese Health Authorities in March 2010, the first Sonolith i-sys lithotripter of the country has been successfully installed in Hitachinaka General Hospital in June. With this new installation, the Sonolith i-sys is now operating in 18 countries.

Now online: check out new HIFU PLANET website The fully revamped HIFU PLANET website for prostate cancer patients looking for information and treatment centers with Ablatherm® HIFU is now online. Check it out on www.hifu-planet.co.uk and www.hifu-planet.fr

Sonolith i-move receives CE marking EDAP TMS' latest modular lithotripter, Sonolith® i-move, is ready for prime-time at EAU congress in Barcelona after receiving CE marking. The device offers exclusive features including infrared stereo-vision system for real-time, three-dimensional ultrasound localization of urinary stones. With the addition of i-move to its range of lithotripters, EDAP TMS now covers all market segments with modern and high-tech systems.

EDAP TMS nominated for European Inventor Award 2010 EDAP TMS is nominated along with Inserm for European Inventor Award 2010 for its work on Ablatherm HIFU for the minimally-invasive treatment of prostate cancer. The Award is presented annually by the European Patent Office (EPO) and European Commission honoring inventors in the field of science and technology .Years of research led to the first HIFU treatment for prostate cancer with Ablatherm in 1993. Up to date, more than 21,000 treatments have been performed worldwide with the device.

EDAP TMS symposium success in Washington D.C. The 3rd International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer held in Washington D.C last week (February 24-27 2010) was a success for EDAP TMS with a highlight on Ablatherm® HIFU during a dedicated session. The pionneers of focal prostate cancer treatment with Ablatherm® presented promising clinical results to the audience composed of international prostate cancer experts.

A Grenoble, on traite les calculs avec le Sonolith i-sys sans anesthésie France 3 Rhône-Alpes a consacré un reportage à l'unité de traitement des calculs urinaires du CHU de Grenoble dirigée par le Professeur Rambeaud et équipée avec le Sonolith® i-sys. Le CHU est pionnier dans le traitement des calculs urinaires sans aucune anesthésie rendu possible par la conception même du Sonolith® i-sys. Retrouvez le reportage en cliquant ici.

Journée de la prostate : vous avez le droit de savoir Aujourd'hui, 15 Septembre 2009, c'est la journée de la prostate organisée dans le cadre de la semaine Européenne de l'Urologie. Cette journée de la prostate a pour but de sensibiliser tout un chacun au cancer de la prostate, son dépistage et ses traitements. A cette occasion, nous mettons en ligne notre nouveau dossier de presse en Français.

First Ablatherm® HIFU sold in Bolivia EDAP TMS' first Ablatherm® HIFU system just got aquired by the Centro de Urologia Avanzada de la Clinica Incor Santa Cruz de la Sierra en Bolivia showing that the technology is penetrating more markets everyday.

Sonolith® i-sys receives FDA approval EDAP TMS' high-end lithotripter Sonolith® i-sys has just been granted FDA approval. The device is now cleared for routine ESWL treatment in the USA. Sonolith® i-sys obtained CE mark in 2007 and has widely been adopted in Europe since. As all lithotripters from the Sonolith® range, the Sonolith® i-sys uses the exclusive Electroconductive technology for the management of urinary tract stones.

Ablatherm HIFU receives approval in Argentina EDAP TMS just obtained approval from the Minitry of Health in Argentina for Ablatherm HIFU for the minimally-invasive treatment of localized prostate cancer. After being approved in Brazil earlier this year, the approval in Argentina shows that Ablatherm HIFU is gaining acceptance in South America. 

AURO publishes official guidelines regarding HIFU treatment  In its latest recommendations, the AURO (Association of Italian Urologists) recommends Ablatherm® HIFU treatment as first-line treatment for localized prostate cancer. This publication coming a year after the publication of similar recommendations by the AFU (French Association of Urology) reinforces the growing place of HIFU in the treatment of prostate cancer.

Ablatherm® HIFU confirms success in South Africa

With 3 new treatment centers in Pretoria, Johannesburg and Durban, Ablatherm confirms its presence in South Africa. The country now counts 4 Ablatherm® HIFU treatment centers in major cities of the country.

Visit www.hifu-planet.com website to view the full list of Ablatherm® HIFU treatment centers.

EAU 2009 in Stockholm highlights HIFU 12.000 urologists attended this year's EAU congress in Stockholm which is a particularly successful edition for EDAP TMS. The EAU hosted the EDAP TMS sponsored HIFU symposium with 200 urologists attending from all over the world. Vincenzo Ficarra from University of Padua, Italy chaired the symposium around the theme of High Intensity Focused Ultrasound in the Modern Urology Practice.

Ablatherm® HIFU is now approved in Brazil Ablatherm® HIFU is now approved in Brazil adding new outlooks for the technology.

With the recent installation of Ablatherm® HIFU in Mexico, the expansion of HIFU is on its way in Latin America.

First Ablatherm® HIFU system is now treating in Mexico. The first Ablatherm® HIFU system was installed in Centro Médico Puerta de Hierro Hospital in Guadalajara this month and Dr. Jorge Gutierrez Aceves successfully performed the first treatments for localized prostate cancer. Mexico is the first country in Latin America to adopt Ablatherm® HIFU and the technology is now available in 26 countries worldwide.

3 Sonolith® i-sys systems are now in operation in Ecuador EDAP TMS installed 3 Sonolith® i-sys systems in Ecuador this January and the first treatments were performed successfully by the teams of highly trained physicans. The 3 Sonolith® i-sys are installed in Quito, the capital of Equator, Guayaquil, the largest city of the country and Cuenca, the capital of Azuay province. The national and local Equatorian media widely relayed the installation of these high-tech ESWL systems.

India treats its first prostate cancer patients with Ablatherm® HIFU

On January 21st, the first Indian patients from Muljibhai Patel Urological Hospital in Nadiad, successfully received Ablatherm® HIFU treatment. The Ablatherm® installed at MPUH is the first one installed in India and the technology is now available in more than 25 countries.

Ultrasound & Therapy Community website is launched EDAP TMS is proud to announce that launching of Ultrasound & Therapy Community website for Ablatherm® HIFU and Sonolith® users : "Continuous education and information network for EDAP TMS users". Designed to link Ablatherm® users via Internet, U&T Community website enables all users to have access to online training, videos, images and clinical publications all in one place.

Ablatherm® HIFU is now available in more than 200 centers. In September 2008, the 200th Ablatherm® HIFU treatment center started treating patients for localized prostate cancer.

2 new Ablatherm® HIFU treatment centers in the Netherlands. EDAP TMS is proud to announce the opening of 2 new Ablatherm® HIFU treatment centers in Zaandam and Roosendaal.

Ablatherm® is now operating in the Netherlands EDAP TMS is proud to announce that Ablatherm® is now available in a new country. Amphia Ziekenhuis in Breda (Netherlands) is the first hospital of the country equipped with Ablatherm®.

New HIFU planet website launched in Germany

EDAP TMS launched a dedicated patient website for German prostate cancer patients seeking information on prostate cancer treatment. Visit HIFU planet at http://www.hifu-planet.de/ . Patients will find all information on Ablatherm® treatment and treatment centers addresses. 

HIFU planet website in Turkish EDAP TMS is proud to announce the launching of its patient website www.hifu-planet.com in Turkish. HIFU planet website is already available in English, French, German, Italian and Spanish and is dedicated to prostate cancer patients looking for information on Ablatherm® HIFU treatment. After only a few days of activity, 400 visits are recorded!

EDAP Highlights Minimally Invasive Robotic HIFU Technology At British Association of Urological Surgeons Annual Meeting Launches "@-REGISTRY" Database in the United Kingdom.